Year archive

InnoCan Pharma Corporation — 2025 filings

All 40 regulatory filings released by InnoCan Pharma Corporation (INNO) in 2025, sourced directly from the official regulator.

40 Filings

2025 Period

2025 filings (40)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2025-12-17	English
News release - English.pdf Regulatory Filings	2025-11-24	English
News release - English.pdf Regulatory Filings	2025-10-15	English
News release - English.pdf Regulatory Filings	2025-09-18	English
News release - English.pdf Regulatory Filings	2025-09-15	English
Material change report - English.pdf Capital/Financing Update	2025-07-31	English
News release - English.pdf Regulatory Filings	2025-06-20	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-06-06	English
Other.pdf Regulatory Filings	2025-06-06	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2025-06-06	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2025-06-06	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-05-28	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-05-28	English
Interim MD&A - English.pdf Management Reports	2025-05-28	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-05-28	English
News release - English.pdf Earnings Release Q1 2025	2025-05-28	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2025-05-07	English
News release - English.pdf Regulatory Filings	2025-05-06	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2025-04-23	English
Material change report - English.pdf Capital/Financing Update	2025-04-15	English
News release - English.pdf Capital/Financing Update	2025-04-07	English
News release - English.pdf Earnings Release FY 2024	2025-03-31	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-03-31	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-03-31	English
Annual MD&A - English.pdf Management Reports	2025-03-31	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-31	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-31	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2024	2025-03-31	English
Material document(s).pdf Capital/Financing Update	2025-03-07	English
Material change report - English.pdf Capital/Financing Update	2025-03-07	English
Material document(s).pdf Capital/Financing Update	2025-03-07	English
Material document(s).pdf Capital/Financing Update	2025-03-07	English
News release - English.pdf Capital/Financing Update	2025-03-07	English
News release - English.pdf Capital/Financing Update	2025-02-27	English
News release - English.pdf Regulatory Filings	2025-02-18	English
News release - English.pdf Regulatory Filings	2025-02-10	English
News release - English.pdf Regulatory Filings	2025-01-29	English
News release - English.pdf Regulatory Filings	2025-01-09	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2025-01-08	English
News release - English.pdf Capital/Financing Update	2025-01-02	English